Home/ Stocks/ SNSE

Sensei Biotherapeutics, Inc. Common Stock

SNSE XNAS

$29.97 -1.78 (-5.43%) ▼ 15-min delayed

Open

$32.27

High

$33.50

Low

$29.96

Volume

71.4K

Market Cap

$41.36M

About Sensei Biotherapeutics, Inc. Common Stock

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Sector: PHARMACEUTICAL PREPARATIONS Employees: 15 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-4,569,000	$-3.62
Q2 2025	$0	$-4,936,000	$-3.91
Q1 2025	$0	$-6,864,000	$-0.27
FY 2024	$0	$-30,157,000	$-1.20

Related Market News

No specific coverage for SNSE yet. Check out our latest market news or earnings calendar.

Get SNSE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Sensei Biotherapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.